CN1768854A - Chinese medicinal capsule with spleen-supplementing, intestine-benefiting function - Google Patents

Chinese medicinal capsule with spleen-supplementing, intestine-benefiting function Download PDF

Info

Publication number
CN1768854A
CN1768854A CN 200510114587 CN200510114587A CN1768854A CN 1768854 A CN1768854 A CN 1768854A CN 200510114587 CN200510114587 CN 200510114587 CN 200510114587 A CN200510114587 A CN 200510114587A CN 1768854 A CN1768854 A CN 1768854A
Authority
CN
China
Prior art keywords
solution
capsule
methanol
preparation
add
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510114587
Other languages
Chinese (zh)
Other versions
CN1768854B (en
Inventor
谭沛
韩正洲
刘志刚
何健
冉繁荣
赵枫林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Resources Sanjiu Medical and Pharmaceutical Co Ltd
Original Assignee
SANJIU PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SANJIU PHARMACEUTICAL CO Ltd filed Critical SANJIU PHARMACEUTICAL CO Ltd
Priority to CN 200510114587 priority Critical patent/CN1768854B/en
Publication of CN1768854A publication Critical patent/CN1768854A/en
Application granted granted Critical
Publication of CN1768854B publication Critical patent/CN1768854B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a Chinese medicinal capsule with spleen-supplementing, intestine-benefiting functions, and the quality controlling method of the preparation, wherein the premix dissoluble portion of the raw material herbs includes astragalus root, pilose asiabell root, amomum fruit, root of herbaceous peony, Chinese angelica root, white atractylodes rhizome and Cinnamomum cassia, and the intestine dissoluble portion comprises corydalis tuber, lychee seed, dried ginger, licorice root, ledebouriella root, banksia rose, psoralea fruit and red halloysite.

Description

A kind of Chinese medicinal capsule preparation with functions of reinforcing spleen and benefiting intestine
Technical field
The present invention relates to a kind of Chinese medicinal capsule preparation, particularly relate to a kind of Chinese medicinal capsule preparation with functions of reinforcing spleen and benefiting intestine.
Background technology
Chronic non-specific ulcerative colitis is comparatively common clinically, the easily colonic mucosa of outbreak and the chronic inflammation enteropathy of Submucosa repeatedly, with lower abdominal pain, diarrhoea or defecate thin, mucus to be arranged or have blood in stool etc. be clinical characters; Because the course of disease is long, outbreak repeatedly is difficult to cure, and the possibility of potential malignant change is arranged, and therefore, the patient is very painful.Owing to be a kind of agnogenic autoimmune disease, therefore still there are not good Therapeutic Method and medicine both at home and abroad.
The doctor trained in Western medicine choice drug is adrenocortical hormone and thyroliberin, and the person of failing to respond to any medical treatment can add with azathioprine or Ismipur, and be no less than 3 months the course of treatment, generally should continue half a year to 2 year.Also can use treatments such as antibacterials prontosil pyridine, bactrim, neomycin, norfloxacin.Adopt the medicine retention enema can obtain certain effect, sleep every night preceding 1 time, 2-3 week is a course of treatment.Theory of Chinese medical science thinks that primary disease belongs to the category of " diarrhea due to hypofunction of the spleen ", adopts the method treatment of invigorating the spleen to arrest diarrhea can obtain certain therapeutic effect.The end of the seventies, the beginning of the eighties, domestic middle medical circles have just begun the clinical research at chronic non-specific ulcerative colitis, adopt the decoction for the treatment colitis of invigorating the spleen and benefiting QI to obtain effect preferably.According to the external treatment with Chinese medicine theory, adopt the medicine of convergence, relieving diarrhea with astringents to carry out colon clysis to control its mark subsequently, oral invigorating the spleen and benefiting QI Chinese medicine is with Zhi Qiben simultaneously, and inside and outside treating both the principal and the secondary aspects of a disease at the same time obtains promising result.But clysmata must just can be carried out in hospital, the several hrs of at every turn need on operating-table, lying on one's side, abdominal distention unbearably, the life-time service patient is difficult to accept.
Summary of the invention
Purpose of the present invention is to provide a kind of Chinese medicinal capsule preparation with functions of reinforcing spleen and benefiting intestine; Another object of the present invention is to provide a kind of preparation method with Chinese medicinal capsule agent of functions of reinforcing spleen and benefiting intestine, and the object of the invention also is to provide the method for quality control of this capsule preparations.
Technical scheme
Chinese medicinal capsule preparation with functions of reinforcing spleen and benefiting intestine of the present invention is made up of following raw material medicaments, proportioning following (by weight):
The said preparation crude drug divides two partly to form, wherein
The gastric solubleness part:
Radix Astragali 150-250 weight portion Radix Codonopsis (rice is fried) 100-200 weight portion
Fructus Amomi 40-80 weight portion Radix Paeoniae Alba 250-400 weight portion
Radix Angelicae Sinensis (parching with earth) the 30-70 weight portion Rhizoma Atractylodis Macrocephalae (parching with earth) 70-140 weight portion
Cortex Cinnamomi 20-40 weight portion.
The molten part of colon:
Rhizoma Corydalis (system) 70-140 weight portion Semen Litchi 70-140 weight portion
Rhizoma Zingiberis (big gun) 40-90 weight portion Radix Glycyrrhizae (processing) 70-140 weight portion
Radix Saposhnikoviae 70-140 weight portion Radix Aucklandiae 70-140 weight portion
Fructus Psoraleae (processed with salt) 70-140 weight portion Halloysitum Rubrum (forging) 250-350 weight portion
Gastric solubleness part, the molten part of colon prepare respectively, and wherein the capsule quantity partly made of gastric solubleness is 2 times of the molten part capsule of colon quantity.
Method for making:
Above gastric solubleness part seven flavors are got Fructus Amomi, Cortex Cinnamomi powder is broken into fine powder, sieves mixing; The five tastes such as all the other Radixs Astragali add water 8-12 doubly to be measured, and soaks after 20-40 minute, decocts 2-3 time, each 1-3 hour, collecting decoction filtered, filtrate decompression concentrates (below 60 ℃) to about 1.10 (60 ℃) of relative density, and room temperature to be chilled to adds ethanol and makes and contain the alcohol amount and be 50-70%, stir evenly, after leaving standstill, get supernatant and reclaim ethanol, concentrating under reduced pressure (below 60 ℃) to relative density is about 1.20 (60 ℃), vacuum drying (below 60 ℃) becomes dry extract, pulverizes; With above-mentioned Fructus Amomi, Cortex Cinnamomi fine powder mixing, to granulate, the Capsules of packing into is made gastric-dissolved capsule.
Molten part eight flavors of above colon are got Halloysitum Rubrum 4/5 amount, add water 8-12 and doubly measure, and decoct 1-2 hour, staticly settle, and get supernatant, and are standby; Remaining Halloysitum Rubrum is ground into fine powder, and is standby.Seven flavors such as all the other Rhizoma Corydalis add water 11-15 doubly to measure, and soak after 20-40 minute, decoct 2-4 time, each 1-2 hour, collecting decoction, filter, filtrate decompression concentrates (below 60 ℃) to about 1.10 (60 ℃) of relative density, room temperature to be chilled to, add ethanol and make the alcohol amount of containing be 50-70%, stir evenly, leave standstill, the supernatant of getting supernatant and above-mentioned Halloysitum Rubrum merges, and reclaims ethanol, and concentrating under reduced pressure (below 60 ℃) to relative density is about 1.20 (60 ℃), vacuum drying (below 60 ℃) becomes dry extract, pulverizes; With Halloysitum Rubrum powder mixing, to granulate, the colon soluble and intestine soluble hollow capsule of packing into is made the colon soluble and intestine soluble capsule.
Method of quality control of the present invention comprises following discriminating and/or content assaying method.
Discrimination method comprises to the discriminating of gastric-dissolved capsule with to the discriminating of the molten part enteric coated capsule of colon content:
Wherein the discrimination method of gastric-dissolved capsule comprises one or more in the following method:
A. the Radix Astragali: get gastric-dissolved capsule content 3g, porphyrize adds n-butyl alcohol 30ml, put in the water-bath reflux 2 hours, and filtered, filtrate is put in the separatory funnel, add 1% sodium hydroxide solution jolting, wash 3 times, each 15ml, discard alkali liquor, the reuse n-butyl alcohol is saturated is washed to neutrality, discards water layer, n-butyl alcohol liquid evaporate to dryness in water-bath, residue adds methanol 1ml makes dissolving, as need testing solution.Get Radix Astragali control medicinal material fine powder 3g,, make the medical material contrast solution according to the preparation method of need testing solution.Other gets the astragaloside reference substance, adds methanol and makes the solution that every 1ml contains 1mg, in contrast product solution.According to thin layer chromatography (" 2005 editions one appendix VI B of Chinese pharmacopoeia) test, draw need testing solution, medical material contrast solution, reference substance solution 5 μ l, put respectively on same silica gel g thin-layer plate, with 12-15: 6-8: lower floor's solution that 1-3 chloroform-methanol-water is placed below 10 ℃ is developing solvent, launch, take out, dry, spray is with 10% ethanol solution of sulfuric acid, and it is clear to be heated to the speckle colour developing at 105 ℃.In the test sample chromatograph, with reference substance and the corresponding position of control medicinal material chromatograph, daylight shows down identical sepia speckle, the 365nm ultra-violet lamp shows identical orange-yellow fluorescence speckle down.
B. the Radix Paeoniae Alba: get gastric-dissolved capsule content 2g, porphyrize adds ethanol 10ml, and jolting 5 minutes filters, and filtrate evaporate to dryness, residue add ethanol 1ml makes dissolving, as need testing solution.Get Radix Paeoniae Alba control medicinal material fine powder 1g,, make the medical material contrast solution according to the preparation method of need testing solution.Other gets the peoniflorin reference substance, adds ethanol and makes every 1ml and contain 1mg solution, in contrast product solution.Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2005 B), draw each 10 μ l of above-mentioned three kinds of solution, put respectively on same silica gel g thin-layer plate, with 35-45: 3-7: 8-12: 0.1-0.4 chloroform-ethyl acetate-methanol-formic acid is developing solvent, launch, take out, dry, spray is with 5% vanillin sulfuric acid solution, and it is clear to be heated to the speckle colour developing.In the test sample chromatograph, with reference substance and the corresponding position of control medicinal material chromatograph on, show identical bluish violet speckle
C. Cortex Cinnamomi: get gastric-dissolved capsule content 1.5g, add ethanol 10ml, close plug, merceration 20 minutes, jolting constantly filters, and filtrate is as need testing solution.Get Cortex Cinnamomi control medicinal material fine powder 0.5g,, make control medicinal material solution according to the preparation method of need testing solution.Other gets the cinnamic aldehyde reference substance, adds ethanol and makes the reference substance solution that every 1ml contains 1 μ l.Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2005 B), draw each 5 μ l of above-mentioned three kinds of solution, put respectively on same silica gel g thin-layer plate, with 15-19: 2-4 petroleum ether (60~90 ℃)-ethyl acetate is developing solvent, launch, take out, dry, spray is with dinitrophenylhydrazine ethanol test solution.In the test sample chromatograph, with reference substance and the corresponding position of control medicinal material chromatograph, show the speckle of same color;
D. Fructus Amomi: get gastric-dissolved capsule content 2g, porphyrize adds absolute ether 20ml, and merceration spends the night.Filter, filtrate volatilizes naturally, and residue adds dehydrated alcohol 1ml makes dissolving, as need testing solution.Get Fructus Amomi control medicinal material fine powder 0.5g,, make the medical material contrast solution according to the preparation method of need testing solution.Get the bornyl acetate reference substance, add dehydrated alcohol and make the solution that every 1ml contains 10 μ l, in contrast product solution.Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2005 B), draw above-mentioned three kinds of each 5ul of solution, respectively with same silica gel g thin-layer plate on, with 20-24: 1 cyclohexane extraction-ethyl acetate is developing solvent, launch, take out, dry, spray is with 5% vanillin sulfuric acid solution, and it is clear to be heated to the speckle colour developing.In the test sample chromatograph, with reference substance and the corresponding position of control medicinal material chromatograph on, show the speckle of same color.
Wherein the molten capsular discrimination method of colon comprises one or more in the following method:
E. Rhizoma Corydalis: get colon soluble and intestine soluble capsule 's content 4g, porphyrize adds ammonia solution 30ml dissolving, puts in the separatory funnel, and the 50ml jolting that adds diethyl ether is extracted, and divides and gets ether layer, reclaims solvent, and residue adds methanol 1ml makes dissolving, as need testing solution.Get Rhizoma Corydalis control medicinal material fine powder 1g, the saturated ether 30ml of ammonification soaked overnight filters, and filtrate evaporate to dryness, residue add methanol 1ml makes dissolving, in contrast medical material solution.Get the tetrahydropalmatine reference substance, add methanol and make the solution that every 1ml contains 1mg, in contrast product solution.Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2005 B), draw each 3 μ l of above-mentioned three kinds of solution, put respectively on same silica gel g thin-layer plate, with 6-8: 3-5: it is developing solvent that 1 normal hexane-chloroform-methanol adds 1 strong ammonia solution, launch, take out, dry, smoked clear with iodine vapor to the speckle colour developing.Inspect under the daylight, in the test sample chromatograph, with reference substance, the corresponding position of control medicinal material chromatograph on, show the speckle of same color; After in air, waving the iodine that adsorbs on the most plate, put under the ultra-violet lamp (365nm) and inspect, in the test sample chromatograph, with reference substance, the corresponding position of control medicinal material chromatograph on, show the fluorescence speckle of same color.
F. Fructus Psoraleae: get colon soluble and intestine soluble capsule 's content 1g, add water 20ml dissolving, aqueous solution adds ethyl acetate 30ml extraction, divides and gets ethyl acetate liquid evaporate to dryness, and residue adds ethyl acetate 1ml makes dissolving, as need testing solution.Get Fructus Psoraleae control medicinal material fine powder 0.5g, add ethyl acetate 20ml, ultrasonic 30 minutes, filter, filtrate evaporate to dryness, residue add ethyl acetate 1ml makes dissolving, as the medical material contrast solution.Get psoralen, isopsoralen reference substance, add ethyl acetate and make the mixed solution that every 1ml contains 2mg, in contrast product solution.Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2005 B), draw each 4 μ l of above-mentioned solution, put respectively on same silica gel g thin-layer plate, with 3-5: 1-2 normal hexane-ethyl acetate is developing solvent, launch, take out, dry, spray is put under the ultra-violet lamp (365nm) and is inspected with 10% potassium hydroxide methanol solution.In the test sample chromatograph, with reference substance, the corresponding position of control medicinal material chromatograph on, show two identical fluorescence speckles.
G. Radix Glycyrrhizae: get colon soluble and intestine soluble capsule 's content 5g, porphyrize adds chloroform 40ml, supersound process 15-30 minute, filter, discard filtrate, filtering residue adds methanol 50ml, supersound process 15-30 minute, filters, filtrate is concentrated into about 5ml, is added on the neutral alumina post (100~200 orders, the 15g that have handled well, on the internal diameter 10~15mm),, collect eluent with 40% methanol 150ml eluting, evaporate to dryness, residue adds water 30ml makes dissolving, with water saturated n-butanol extraction 2-3 time, and each 25ml, merge n-butyl alcohol liquid, with ammonia scrubbing 2-4 time, each 20ml, n-butyl alcohol liquid is put evaporate to dryness in the water-bath, residue adds the 1ml dissolve with methanol, as need testing solution.Extracting liquorice control medicinal material fine powder 2g according to the preparation method of need testing solution, makes control medicinal material solution.Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2005 B), draw above-mentioned two kinds of each 8ul of solution, put respectively on same silica gel g thin-layer plate, with 13-17: 38-45: 20-25: lower floor's solution that 8-12 chloroform-ethyl acetate-methanol-water is placed below 10 ℃ is developing solvent, launch, take out, dry, spray is with 10% ethanol solution of sulfuric acid, and it is clear to be heated to the speckle colour developing at 105 ℃.Inspect under the daylight, in the test sample chromatograph, with the corresponding position of control medicinal material chromatograph on, show the speckle of same color; Put under the ultra-violet lamp (365nm) and inspect, in the test sample chromatograph, with the corresponding position of control medicinal material chromatograph on, show the fluorescence speckle of same color.
H. the thin layer chromatography identification experiment of Radix Saposhnikoviae: get colon soluble and intestine soluble capsule 's content 1g, porphyrize adds acetone 20ml, and supersound process 15-25 minute, filter, filtrate evaporate to dryness, residue add ethanol 1ml makes dissolving, as need testing solution.Get Radix Saposhnikoviae control medicinal material fine powder 1g,, make control medicinal material solution according to the preparation method of need testing solution.According to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2005 B) test, draw each 15 μ l of above-mentioned solution, put in same silica gel G F respectively 254On the lamellae, with 7-9: 1 chloroform-methanol is developing solvent, launches, and takes out, and dries, and puts under the uviol lamp (254nm) and inspects.In the test sample chromatograph, with the corresponding position of control medicinal material on, show the speckle of same color.
Content assaying method comprises to be measured and to the molten part psoralen of colon assay the content of paeoniflorin of gastric-dissolved capsule:
Content of paeoniflorin is surveyed:
The selection of chromatographic column: adopt the octadecylsilane chemically bonded silica chromatographic column.
The selection of mobile phase: the ratio of acetonitrile-water is 15-19: 75-88
The detection wavelength is 230nm, flow velocity 1.0ml/min.
Number of theoretical plate calculates by the peoniflorin peak should be not less than 1500.
The preparation of need testing solution: get gastric-dissolved capsule content 0.3g, the accurate title, decide, and puts in the 25ml measuring bottle, add the about 20ml of methanol, supersound process, power, 150-300W, frequency, 40-70KHz, 20-40 minute, put coldly, add methanol to scale, shake up, leave standstill, get supernatant, filter with microporous filter membrane (0.45 μ m), get filtrate, promptly.
The assay of psoralen
Instrument and reagent:
Chromatographic column: octadecyl silane chromatographic column; The methanol of mobile phase: 45-55: 45-55-1% glacial acetic acid or methanol-acetonitrile-water or methanol-water; The detection wavelength is 245nm; Flow velocity 0.8ml/min; Column temperature 25-40 ℃.Number of theoretical plate calculates by the psoralen peak should be not less than 2000.
The preparation of need testing solution: get colon soluble and intestine soluble capsule 's content 0.4g, put in the 25ml measuring bottle, add the about 20ml of methanol, supersound process power, 150-300W, frequency, 40-70KHz 20-40 minute, is put cold, add methanol to scale, shake up, leave standstill, get supernatant, filter with microporous filter membrane (0.45 μ m), get filtrate, promptly.
Beneficial effect
Preparation of the present invention has great pharmacological effects and therapeutic effect, taking dose is little simultaneously, quality stability is good, the discriminating medical material of selecting and as the composition of assay, can reach effective control to the quality of product, and, make method precision, sensitivity, stability all higher by to each method screening.We make branch colloidal sol capsule preparation with gastric solubleness and the molten part of colon, and layer segment has promoted effective ingredient the absorbing of specific part in colonic location dissolving in can making, and gives full play to the advantage of traditional Chinese medical science treating both the principal and secondary aspects of a disease, obviously improves the curative effect of medicine.The tradition pill, have some inevitable shortcomings: wayward as each position dissolving of gastrointestinal, local curative effect is undesirable, taking dose big (once taking 6g) and make the patient be difficult to swallow, the medicated powder of making a living entirely is used as medicine and makes health examination very difficult up to specification, molten in vivo diffusing absorption slowly and bioavailability is low, dissolve scattered time limit is difficult for reaching shortcomings such as requirement.
Following experiment and embodiment are used to further specify but are not limited to the present invention.
Experimental example 1 reinforcing spleen and benefiting intestine capsule is to the influence of 2,4 dinitrochlorobenzene type colitis
After rat modeling success, press 20ml/kg, the qd gastric infusion, continuous 14 days, normal group and model control group gavaged the distilled water of equivalent.12 hours eye socket veins are got blood behind the last medicine, by content and myeloperoxidase (MPO) (MPO) activity of biotinylation kit requirement with 721 spectrophotometric determination serum lactate dehydrogenase (SLD)s (LDH), serum amylase (AMS).Put to death rat then and get colon (anus is to ileocecus), observe general form and change, press the scoring of table 1 standard.Get colon 5cm long (apart from anus 3cm) simultaneously and claim weight in wet base, 10% formaldehyde fixed, the routine paraffin wax embedding, HE dyeing tissues observed form changes, and presses the scoring of table 2 standard.
Table 1 general form damage standards of grading
The general form performance Scoring
Adhesion ulcer and inflammation Do not have slight (colon and its hetero-organization are peeled off transaction) severe and do not have contrafluxion; NIP 1 place's ulcer is not accompanied hyperemia or ulcer companion inflammation (hyperemia or intestines wall thickening)>2 place's ulcer and/or inflammation>1cm ulcer and/or the inflammation>2cm of ulcer companion inflammation (hyperemia or intestines wall thickening)>2 place of intestines wall thickening 1 place; The every increase of extent of disease 1cm, score adds 1 0 1 2 0 1 2 3 4 5 6~8
Table 2 Histological injury standards of grading
Histology's performance Scoring
Ulcer Big ulcer>the 3mm of no aphtha<3mm 0 1 2
Inflammation There is not slight (inflammatory cell infiltration is few, goblet cell reduce light) severe (inflammatory cell infiltration is many, goblet cell reduce obvious) 0 1 2
Granuloma Nothing has 0 1
The pathological changes degree of depth No tela submucosa flesh layer placenta percreta 0 1 2 3
Fibrosis There is not slight severe 0 1 2
Table 3 pair 2,4 dinitrochlorobenzene type colitis rats
The influence of colon general form, Histological injury (n=10 x ± SD)
Group Dosage (g/kg) The anatomical lesion score Histological injury's score
Normal group model+distilled water model+reinforcing spleen and benefiting intestine capsule model+reinforcing spleen and benefiting intestine capsule model+reinforcing spleen and benefiting intestine capsule model+pill for strengthening spleen and intestines model+SASP - - 6.60 3.30 1.65 3.30 0.55 0±0 6.60±0.97## 3.00±0.97** 2.90±1.07** 4.90±1.20** 4.00±1.25** 3.30±1.34** 0.30±0.48 8.10±1.10## 1.90±1.66** 2.40±2.07** 4.60±1.71** 4.80±1.93** 3.60±1.35**
# refers to P and normal group relatively; * refer to that P and model group are relatively;
# or * P<0.05; ## or * * P<0.01, down together
Table 4 pair 2,4 dinitrochlorobenzene type colitis
The influence of rat blood serum biochemical indicator (n=10 x ± SD)
Group Dosage (g/kg) MPO(U/L) LDH (u/dl) AMS(u/dL)
Normal group model+distilled water model+reinforcing spleen and benefiting intestine capsule model+reinforcing spleen and benefiting intestine capsule model+reinforcing spleen and benefiting intestine capsule model+pill for strengthening spleen and intestines model+SASP - - 6.60 3.30 1.65 3.30 0.55 43.85±3.38 57.91±8.75## 39.43±3.58** 40.98±5.01** 52.90±5.01 47.49±4.97** 43.56±4.89** 4243.20±1705.31 11840.80±3869.17## 2750.60±1347.21** 3780.40±1245.69** 5167.40±2055.52** 5050.80±1413.70** 4160.20±1347.28** 766.90±7.09 720.60±22.74## 765.20±7.11** 763.50±7.82** 763.30±9.42** 756.40±7.75** 764.80±8.48**
Table 5 pair 2,4 dinitrochlorobenzene type colitis
The influence of rat body weight and colon weight (n=10 x ± SD)
Group Dosage (g/kg) Colon weight in wet base (g) Administration forebody-afterbody method of double differences value (g)
Normal group model+distilled water model+reinforcing spleen and benefiting intestine capsule model+reinforcing spleen and benefiting intestine capsule model+reinforcing spleen and benefiting intestine capsule model+pill for strengthening spleen and intestines model+SASP - - 6.60 3.30 1.65 3.30 0.55 0.493±0.042 1.423±0.449## 0.796±0.168** 0.824±0.198** 1.076±0.796 1.018±0.305** 0.981±0.196** ↑42.60±17.68 ↓8.60±2.95## ↓4.40±1.71** ↓5.00±1.64* ↓5.80±2.10 ↓6.70±2.83* ↓5.80±2.20**
↑ to represent to increase, ↓ expression reduces, down together
The result shows (table 3, table 4, table 5): the reinforcing spleen and benefiting intestine capsule of high, medium and low dosage all can significantly reduce 2, general form, Histological injury's degree of 4 dinitrochlorobenzene type colitis rat colons, alleviate colon weight and reduction Serum LDH content and MPO activity, increase the content of serum AMS, the degree that loses weight when reducing colitis, compare P<0.05~0.01 with model group, show that the reinforcing spleen and benefiting intestine capsule has certain therapeutical effect to ulcerative colitis.This effect is better than the Spleen Invigorating and Intestine Tonifying Pill group and the sulfasalazine group of dose,equivalent, P<0.01.
Experimental example 2 reinforcing spleen and benefiting intestine capsules are to the influence of acetic acid type colitis
After rat modeling success, press 20ml/kg, the qd gastric infusion, continuous 14 days, normal group and model control group gavaged the distilled water of equivalent.12 hours execution rats are got colon (anus is to ileocecus) behind the last medicine, the observation general form changes, get colon 5cm long (apart from anus 3cm) simultaneously and claim weight in wet base, 10% formaldehyde fixed, the routine paraffin wax embedding, HE dyeing tissues observed form changes, and presses table 1, table 2 criterion calculation colitis general form and tissue morphology degree of injury.
Table 6 pair acetic acid type colitis rat
The influence of colon general form, Histological injury (n=10 x ± SD)
Group Dosage (g/kg) The anatomical lesion score Histological injury's score
Normal group model+distilled water model+reinforcing spleen and benefiting intestine capsule model+reinforcing spleen and benefiting intestine capsule model+reinforcing spleen and benefiting intestine capsule model+pill for strengthening spleen and intestines model+SASP - - 6.60 3.30 1.65 3.30 0.55 0.00±0.00 5.30±1.06## 2.30±1.25** 2.80±1.32** 3.30±1.77** 3.70±2.11* 3.70±1.64* 0.10±0.32 8.10±0.57## 2.60±1.26** 3.30±0.67** 4.20±1.55** 4.60±1.51** 3.80±1.48**
The influence of table 7 pair acetic acid type colitis rat body weight and colon weight (n=10 x ± SD)
Group Dosage (g/kg) Colon weight in wet base (g) Administration forebody-afterbody method of double differences value (g)
Normal group model+distilled water model+reinforcing spleen and benefiting intestine capsule model+reinforcing spleen and benefiting intestine capsule model+reinforcing spleen and benefiting intestine capsule model+pill for strengthening spleen and intestines model+SASP - - 6.60 3.30 1.65 3.30 0.55 0.643±0.124 1.066±0.172## 0.837±0.099** 0.876±0.145* 0.855±0.200* 0.865±0.144* 0.815±0.144** ↑36.10±11.45 ↓7.50±1.90## ↓3.00±1.33** ↓4.20±1.75* ↓6.30±2.11 ↓5.60±1.07** ↓5.20±1.40**
The result shows (table 6, table 7): the reinforcing spleen and benefiting intestine capsule of high, medium and low dosage can reduce significantly all that acetic acid type colitis rat body weight alleviates and the degree of the general form of colon, tissue morphology damage, and significantly alleviate colon weight, compare P<0.05~0.01 with model group, show that the reinforcing spleen and benefiting intestine capsule has certain therapeutical effect to ulcerative colitis.This effect is better than the Spleen Invigorating and Intestine Tonifying Pill group and the sulfasalazine group of dose,equivalent, P<0.05.
Experimental example 3 reinforcing spleen and benefiting intestine capsules are to the influence of capillary permeability
After the mice random packet, press 20ml/kg, the qd gastric infusion, continuous 4 days, matched group gavaged the distilled water of equivalent.Behind the last medicine 1 hour by the capillary permeability laboratory method, the quantitative 0.5% azovan blue normal saline of intravenous injection, the quantitative acetic acid of while lumbar injection, put to death mice behind the 15min, open the abdominal cavity, with the normal saline flushing abdominal cavity and collect flushing liquor, with the content of 721 spectrophotometric determination mouse peritoneal eluate (10ml) azovan blue.
The influence of table 8 pair capillary permeability (n=11, x ± SD)
Group Dosage (g/kg) The seepage discharge of azovan blue (OD value)
Distilled water reinforcing spleen and benefiting intestine capsule reinforcing spleen and benefiting intestine capsule reinforcing spleen and benefiting intestine capsule Spleen Invigorating and Intestine Tonifying Pill indometacin - 9.60 4.80 2.40 4.80 0.02 0.208±0.123 0.077±0.032## 0.088±0.061 ## 0.095±0.061# 0.091±0.045## 0.028±0.011##
The result shows (table 8): the seepage discharge of azovan blue when the reinforcing spleen and benefiting intestine capsule of high, medium and low dosage all can significantly reduce acetic acid and causes the mouse peritoneal capillary permeability and increase, compare with matched group, P<0.05~0.01, show that the reinforcing spleen and benefiting intestine capsule can reduce the permeability of blood capillary, has certain antiinflammatory action.This effect does not relatively have significant difference, P>0.05 with Spleen Invigorating and Intestine Tonifying Pill.
Experimental example 4 reinforcing spleen and benefiting intestine capsule xylol cause the influence of mouse ear inflammatory reaction
With mice group and administration, with experimental example 1, dripped equivalent caused by dimethylbenzene xylene inflammation by the mice ear method to each group mice left side ear in 1 hour behind the last medicine, take off cervical vertebra in 15 minutes and put to death mice, along auricle baseline clip two ears, and lay auricle with card punch in same position, and weigh, be inflammation swelling degree with two ear weight differences.
Table 9 xylol causes influence (n=11, the x ± SD) of mouse ear inflammatory reaction
Group Dosage (g/kg) Ear inflammation swelling degree difference (mg)
Distilled water reinforcing spleen and benefiting intestine capsule reinforcing spleen and benefiting intestine capsule reinforcing spleen and benefiting intestine capsule Spleen Invigorating and Intestine Tonifying Pill indometacin - 9.60 4.80 2.40 4.80 0.02 3.70±2.06 1.70±0.78## 2.18±1.25# 2.66±2.02 3.00±1.98 1.04±0.35##
The result shows (table 9): high dose and middle dosage reinforcing spleen and benefiting intestine capsule can significantly alleviate the swelling degree of mice caused by dimethylbenzene xylene ear inflammatory reaction, compare P<0.05 with matched group, show that the reinforcing spleen and benefiting intestine capsule has certain antiinflammatory action.This effect does not relatively have significant difference, P>0.05 with Spleen Invigorating and Intestine Tonifying Pill.
Experimental example 5 reinforcing spleen and benefiting intestine capsules are to the influence of gastrointestinal function
1, to the influence of mouse small intestine charcoal end propelling rate
The mice medication is with experimental example 1, allow by small intestinal charcoal end propulsion trial method behind the last medicine and respectively organized the mice fasting 24 hours, gavage the medicinal liquid 20ml/kg that contains 5% carbon powder then, put to death mice after 15 minutes, press small intestinal carbon powder propulsion trial method and calculate mouse small intestine carbon powder propelling rate.
The influence of table 10 pair mouse small intestine charcoal end propelling rate (n=12, x ± SD)
Group Dosage (g/kg) Small intestinal total length (cm) Advance length (cm) Carbon powder propelling rate (%)
Distilled water reinforcing spleen and benefiting intestine capsule reinforcing spleen and benefiting intestine capsule reinforcing spleen and benefiting intestine capsule Spleen Invigorating and Intestine Tonifying Pill atropine - 9.60 4.80 2.40 4.80 0.48mg 52.50±3.23 52.75±2.99 53.50±2.07 53.33±3.42 52.67±3.65 54.17±3.16 20.92±5.35 17.17±2.52 17.50±3.45 20.50±3.29 18.17±3.69 13.75±1.76 39.71±9.19 34.96±4.83# 32.69±6.22# 38.46±5.84 34.35±5.95 25.53±4.01##
The result shows (table 10): the reinforcing spleen and benefiting intestine capsule of high dose and middle dosage can significantly suppress mouse small intestine carbon powder propelling rate, compares P<0.05 with matched group, shows that the reinforcing spleen and benefiting intestine capsule has the effect that suppresses the mice gastrointestinal peristalsis.The Spleen Invigorating and Intestine Tonifying Pill of this effect and dose,equivalent does not relatively have significant difference, P>0.05.
2, to Radix Et Rhizoma Rhei type mice with spleen deficiency defecation time, just and the influence of body weight
Mice is pressed the modeling in continuous 8 days of the insufficiency of the spleen molding of Radix Et Rhizoma Rhei type, and the medicine group is in first day while of modeling gastric infusion, and once a day, continuous 7 days, normal control group and model control group gavaged the distilled water of equivalent.Allow mice fasting 24 hours by charcoal end efflux time and feces color dot algoscopy behind the last medicine, gavage the medicinal liquid 20ml/kg that contains 5% charcoal end then, what each mice of opening entry was arranged row's melena in time and 2 hours of melena first behind the medicine counts (do not have row's melena person in 2 hours, then calculated by 2 hours).
Table 11 pair Radix Et Rhizoma Rhei type mice with spleen deficiency defecation time and influence just (n=13, x ± SD)
Group Dosage (g/kg) Defecation rate (%) Begin to arrange the melena time (min) Row's melena number (point/2h)
Normal control group model+distilled water model+reinforcing spleen and benefiting intestine capsule model+reinforcing spleen and benefiting intestine capsule model+reinforcing spleen and benefiting intestine capsule model+Spleen Invigorating and Intestine Tonifying Pill - - 9.60 4.80 2.40 4.80 31% 100%## 31.00%** 54.00%** 69.00%* 69.00%* 112.31±11.36 23.92±23.02## 90.54±46.26** 79.62±46.54** 54.54.00±52.67 59.77±52.48* 0.62±1.04 3.31±1.80## 0.62±1.12** 1.31±1.60** 1.77±1.74* 2.31±2.06
The influence of table 12 pair Radix Et Rhizoma Rhei type mice with spleen deficiency body weight (n=13, x ± SD)
Group Dosage (g/kg) Body weight (g) before the medicine Body weight behind the medicine (g) Difference (g)
Normal control group model+distilled water model+reinforcing spleen and benefiting intestine capsule model+reinforcing spleen and benefiting intestine capsule model+reinforcing spleen and benefiting intestine capsule model+Spleen Invigorating and Intestine Tonifying Pill - - 9.60 4.80 2.40 4.80 20.85±1.63 20.62±1.50 20.69±1.32 20.92±1.38 20.08±1.26 20.46±1.13 23.92±0.95 18.62±1.61 22.69±2.39 22.31±2.14 20.15±1.77 20.38±1.19 ↑3.08±1.26 ↓2.00±1.15## ↑2.00±1.41** ↑1.38±1.04** ↑0.08±2.10** ↓0.08±0.86**
The result shows (table 11, table 12): but the defecation time of the equal significant prolongation Radix Et Rhizoma Rhei type model of spleen deficiency mice of the reinforcing spleen and benefiting intestine capsule of high, medium and low dosage, the interior row of minimizing 2h melena is counted and is arranged the melena rate, reduce the degree that the model of spleen deficiency mice loses weight, compare P<0.05~0.01 with model control group.Show that the reinforcing spleen and benefiting intestine capsule has some improvement to Radix Et Rhizoma Rhei type mice with spleen deficiency symptom, this may be relevant with its anti-diarrhea effect.The Spleen Invigorating and Intestine Tonifying Pill of this effect and dose,equivalent does not relatively have significant difference, P>0.05.
3, to the influence of blood stasis model hemorheology of rat
After the rat random packet, 20ml/kg, the qd gastric infusion, continuous 15 days, normal control group and model control group gavaged the distilled water of equivalent.Pressed depression of liver-QI and cold-condensing type syndrome of blood stasis modelling subcutaneous injection epinephrine on the 13rd day in administration, every day 2 times, and between 2 injections, soak frozen water once, modeling in continuous 2 days.12 hours socket of the eye veins are got blood behind the last medicine, take into account LBY-Nn Trace Blood slurry viscosity instrumentation with the rotary blood viscosity of LBY-N6A type and decide whole blood viscosity (low cut, height cut), whole blood reduced viscosity (low cut, height cut), plasma viscosity, RBC hematocrit, RBC aggregate index, RBC deformation index etc.
The influence of table 13 pair Blood stasis hemorheology of rat (n=10, x ± SD)
Group Dosage (g/kg) Whole blood viscosity (low cutting) (mPa.s) Whole blood viscosity (height is cut) (mPa.s)
Normal group model control group reinforcing spleen and benefiting intestine capsule reinforcing spleen and benefiting intestine capsule reinforcing spleen and benefiting intestine capsule pill for strengthening spleen and intestines Fufang Danshen Pian - - 6.60 3.30 1.65 3.30 0.55 12.799±4.150 19.375±3.964 ## 15.396±2.299* 18.053±4.263 16.460±3.966 17.441±3.911 13.757±1.896** 4.913±0.772 6.439±0.699 ## 5.586±0.708* 6.028±0.841 5.897±0.977 6.016±0.729 5.105±0.531**
The influence of table 14 pair syndrome of blood stasis hemorheology of rat (n=10, x ± SD)
Group Dosage (g/kg) Plasma viscosity (mPa.s) RBC hematocrit (%)
Normal group model control group reinforcing spleen and benefiting intestine capsule reinforcing spleen and benefiting intestine capsule reinforcing spleen and benefiting intestine capsule pill for strengthening spleen and intestines Fufang Danshen Pian - - 6.60 3.30 1.65 3.30 0.55 1.389±0.104 1.618±0.208 ## 1.439±0.080* 1.490±0.122 1.424±0.094* 1.596±0.122 1.375±0.061** 45.500±6.587 49.00±3.432 46.800±2.573 48.100±4.202 47.400±3.098 48.900±2.644 47.800±2.658
The influence of table 15 pair syndrome of blood stasis hemorheology of rat (n=10, x ± SD)
Group Dosage (g/kg) Whole blood reduced viscosity (low cutting) (mPa.s) Whole blood reduced viscosity (height is cut) (mPa.s)
Normal group model control group reinforcing spleen and benefiting intestine capsule reinforcing spleen and benefiting intestine capsule reinforcing spleen and benefiting intestine capsule pill for strengthening spleen and intestines Fufang Danshen Pian - - 6.60 3.30 1.65 3.30 0.55 24.437±5.895 36.010±5.803 ## 29.964±5.383* 34.085±6.632 31.563±6.587 33.096±5.724 25.870±3.459** 7.712±0.805 9.848±1.029 ## 8.916±1.689 9.422±1.384 9.426±1.634 9.285±1.097 7.821±1.136**
The influence of table 16 pair syndrome of blood stasis hemorheology of rat (n=10, x ± SD)
Group Dosage (g/kg) The RBC aggregate index The RBC deformation index
Normal group model control group reinforcing spleen and benefiting intestine capsule reinforcing spleen and benefiting intestine capsule reinforcing spleen and benefiting intestine capsule pill for strengthening spleen and intestines Fufang Danshen Pian - - 6.60 3.30 1.65 3.30 0.55 2.544±0.454 2.987±0.349* 2.755±0.186 2.963±0.365 2.772±0.235 3.112±0.527 2.687±0.179* 0.874±0.090 0.869±0.074 0.894±0.091 0.890±0.072 0.912±0.063 0.890±0.105 0.862±0.068
The result shows (table 13, table 14, table 15, table 16): the reinforcing spleen and benefiting intestine capsule of high dose group can significantly reduce stasis syndrome disease rat whole blood viscosity (low cutting with height cut), whole blood reduced viscosity (low cutting) and plasma viscosity; Low dose group also can reduce plasma viscosity, compares P<0.05 with model group.Little to RBC hematocrit, deformation index and aggregate index influence, compare P>0.05 with model group.Prompting: the reinforcing spleen and benefiting intestine capsule has some improvement to the hemorheological property of stasis syndrome disease.Relatively there is not significant difference, P>0.05 with the Spleen Invigorating and Intestine Tonifying Pill of dose,equivalent.
The experiment of experimental example 6 assays
(1). the paeoniflorin content determination experiment
1, method:
Instrument and reagent:
High performance liquid chromatograph: the P680 of Dai An company pump, PDA-100 diode array detector, ASI-100 automatic sampler
Acetonitrile: chromatographically pure, water: ultra-pure water, other reagent are analytical pure, the peoniflorin reference substance that assay is used is provided by Nat'l Pharmaceutical ﹠ Biological Products Control Institute.
The selection of chromatographic column: adopt the octadecylsilane chemically bonded silica chromatographic column,, can reach the purpose of separation determination through test.Experiment chromatographic column adopting: Dalian Yi Lite ODS-AP 200*4.6mm, 5 μ m;
The selection of mobile phase: acetonitrile-water (17: 83).
The detection wavelength is 230nm, flow velocity 1.0ml/min.
Number of theoretical plate calculates by the peoniflorin peak should be not less than 1500.
The preparation of need testing solution: get gastric-dissolved capsule content 0.3g, the accurate title, decide, and puts in the 25ml measuring bottle, add the about 20ml of methanol, supersound process (power 200W, frequency 59KHz) 30 minutes, put cold, add methanol to scale, shake up, leave standstill, get supernatant, filter with microporous filter membrane (0.45 μ m), get filtrate, promptly.Every of gastric-dissolved capsule contains the Radix Paeoniae Alba with peoniflorin (C 23H 28O 11) meter, must not be less than 3.00mg
2, method is investigated
The linear preparation precision of investigating reference substance solution takes by weighing 36 hours peoniflorin reference substance 18.5mg of drying in the phosphorus pentoxide vacuum drying apparatus, puts in the 100ml measuring bottle, adds dissolve with methanol and is settled to scale, promptly.
Accurate reference substance solution 4,6,8,16, the 24 μ l that draw of regression equation calculation, inject chromatograph of liquid, measure chromatographic peak area and be respectively 7.8627,15.8282,23.6600,52.6845,81.4952, with the peoniflorin sample size is abscissa, with the chromatographic peak area is vertical coordinate, and the drawing standard curve returns through linearity, get regression equation: Y=19.814X-6.2152, r=0.9999.The result shows: the sample size of peoniflorin is good linear relationship with its peak area in 0.74-4.44 μ g scope.
Stability experiment is got need testing solution, respectively at preparation 0,4,8,12, measures after 24 hours, and peak area is respectively 22.7272,22.8541,23.1243,22.3584,22.2145 RSD=1.46% as a result.Show that sample solution kept stable in 24 hours.
The precision test: get the peoniflorin reference substance solution, repeat sample introduction 5 times, each 10 μ l measure peak area and are respectively 32.2631,32.9048,32.2549,32.5810,32.2941, RSD=0.78%.By The effects such as linearity, stability, precision, illustrate that this content assaying method precision, sensitivity, stability are all higher.
(2) assay of psoralen
1, method:
Instrument and reagent:
High performance liquid chromatograph: the P680 of Dai An company pump, PDA-100 diode array detector, ASI-100 automatic sampler
Methanol: chromatographically pure, water: ultra-pure water, other reagent are analytical pure, the psoralen reference substance that assay is used is provided by Nat'l Pharmaceutical ﹠ Biological Products Control Institute.
Chromatographic column: octadecyl silane chromatographic column; Mobile phase: methanol-water (50: 50); The detection wavelength is 245nm; Flow velocity 0.8ml/min; 25 ℃ of column temperatures.Number of theoretical plate calculates by the psoralen peak should be not less than 2000.
The selection of mobile phase: methanol-1% glacial acetic acid, methanol-acetonitrile-water, methanol-water all can be used as the flow phase system of assay, chromatographic column adopts reversed-phase column (250*4.6mm more, 5 μ m), detect wavelength and be 245nm, column temperature generally is controlled at 25,35,40 ℃.
The preparation of need testing solution: get the content under the colon soluble and intestine soluble capsule content uniformity item, porphyrize is got 0.4g, the accurate title, decide, and puts in the 25ml measuring bottle, adds the about 20ml of methanol, supersound process (power 200W, frequency 59KHz) 30 minutes is put cold, add methanol to scale, shake up, leave standstill, get supernatant, filter with microporous filter membrane (0.45 μ m), get filtrate, promptly.Every of colon soluble and intestine soluble capsule contains Fructus Psoraleae with psoralen (C 11H 6O 3) meter, must not be less than 0.35mg.
2, method is investigated
The linear preparation precision of investigating reference substance solution takes by weighing psoralen reference substance 2.5mg, puts in the 100ml measuring bottle, adds dissolve with methanol, and is fixed molten to scale, promptly.
Accurate psoralen reference substance solution 1,4,8,16, the 24 μ l that draw of the calculating of regression equation, inject chromatograph of liquid, measure chromatographic peak area, peak area is respectively 4.0056,16.6624,35.6612,72.3456,111.5657, with the psoralen sample size is abscissa, is vertical coordinate with the chromatographic peak area, returns through linearity, get regression equation: Y=187.30X-1.5866, r=0.9998.The result shows: the sample size of psoralen is good linear relationship with its peak area in 0.025~0.600 μ g scope.
Stability test is got need testing solution, respectively at preparation 0,4,8,12, measures after 24 hours, and peak area is respectively 28.3669,28.2147,28.6585,27.8294,27.9516, RSD=1.17%.Show that sample solution kept stable in 24 hours.
The psoralen reference substance solution is got in the precision test, repeats sample introduction 5 times, and each 10 μ l measure peak area and are respectively 45.2279,45.4865,46.0248,45.9824,45.1978, RSD=0.78%.By The effects such as linearity, stability, precision, illustrate that this content assaying method precision, sensitivity, stability are all very high.
Following embodiment all can realize the effect of above-mentioned experimental example.
Embodiment 1:Capsule
Place ten thousand
The gastric solubleness part:
Radix Astragali 200g Radix Codonopsis (rice is fried) 150g Fructus Amomi 60g
Radix Paeoniae Alba 300g Radix Angelicae Sinensis (parching with earth) the 50g Rhizoma Atractylodis Macrocephalae (parching with earth) 100g
Cortex Cinnamomi 30g
The molten part of colon:
Rhizoma Corydalis (system) 100g Semen Litchi 100g Rhizoma Zingiberis (big gun) 60g
Radix Glycyrrhizae (processing) 100g Radix Saposhnikoviae 120g Radix Aucklandiae 100g
Fructus Psoraleae (processed with salt) 100g Halloysitum Rubrum (forging) 300g
Method for making
Above gastric solubleness part seven flavors are got Fructus Amomi, Cortex Cinnamomi powder is broken into fine powder, sieves mixing; The five tastes such as all the other Radixs Astragali add 10 times of amounts of water, soak after 30 minutes, decoct secondary, each 2 hours, collecting decoction filtered, filtrate decompression concentrates (below 60 ℃) to about 1.10 (60 ℃) of relative density, and room temperature to be chilled to adds ethanol and makes that to contain the alcohol amount be 60%, stir evenly, after leaving standstill 24 hours, get supernatant and reclaim ethanol, concentrating under reduced pressure (below 60 ℃) to relative density is about 1.20 (60 ℃), vacuum drying (below 60 ℃) becomes dry extract, pulverizes; With above-mentioned Fructus Amomi, Cortex Cinnamomi fine powder mixing, to granulate, the Capsules of packing into is made gastric-dissolved capsule.
Molten part eight flavors of above colon are got Halloysitum Rubrum 4/5 amount, add 10 times of amounts of water, decoct 1 hour, staticly settle, and get supernatant, and are standby; Remaining Halloysitum Rubrum is ground into fine powder, and is standby.Seven flavors such as all the other Rhizoma Corydalis add 13 times of amounts of water, soak after 30 minutes, decoct three times, each 1.5 hours, collecting decoction, filter, filtrate decompression concentrates (below 60 ℃) to about 1.10 (60 ℃) of relative density, room temperature to be chilled to, add ethanol and make that to contain alcohol amount be 60%, stir evenly, left standstill 24 hours, the supernatant of getting supernatant and above-mentioned Halloysitum Rubrum merges, and reclaims ethanol, and concentrating under reduced pressure (below 60 ℃) to relative density is about 1.20 (60 ℃), vacuum drying (below 60 ℃) becomes dry extract, pulverizes; With Halloysitum Rubrum powder mixing, to granulate, the colon soluble and intestine soluble hollow capsule of packing into is made the colon soluble and intestine soluble capsule.
Make 1000 of capsules (wherein gastric solubleness is partly made 667 of gastric-dissolved capsules, and enteric is partly made 333 of colon soluble and intestine soluble capsules).
Usage and dosage: oral, 3 (2 of gastric-dissolved capsules, 1 of colon soluble and intestine soluble capsule) on the one, 3 times on the one; The child is cut down according to the circumstance; Serious symptom dosage or follow the doctor's advice.30 days is a course of treatment, generally serve on 2-3 the course of treatment.
Embodiment 2: capsule
Prescription
The gastric solubleness part:
Radix Astragali 220g Radix Codonopsis (rice is fried) 160g Fructus Amomi 50g
Radix Paeoniae Alba 320g Radix Angelicae Sinensis (parching with earth) the 40g Rhizoma Atractylodis Macrocephalae (parching with earth) 90g
Cortex Cinnamomi 30g
The molten part of colon:
Rhizoma Corydalis (system) 110g Semen Litchi 120g Rhizoma Zingiberis (big gun) 70g
Radix Glycyrrhizae (processing) 110g Radix Saposhnikoviae 100g Radix Aucklandiae 80g
Fructus Psoraleae (processed with salt) 90g Halloysitum Rubrum (forging) 280g
Method for making
Above gastric solubleness part seven flavors are got Fructus Amomi, Cortex Cinnamomi powder is broken into fine powder, sieves mixing; The five tastes such as all the other Radixs Astragali add 10 times of amounts of water, soak after 30 minutes, decoct secondary, each 2 hours, collecting decoction filtered, filtrate decompression concentrates (below 60 ℃) to about 1.10 (60 ℃) of relative density, and room temperature to be chilled to adds ethanol and makes that to contain the alcohol amount be 60%, stir evenly, after leaving standstill 24 hours, get supernatant and reclaim ethanol, concentrating under reduced pressure (below 60 ℃) to relative density is about 1.20 (60 ℃), vacuum drying (below 60 ℃) becomes dry extract, pulverizes; With above-mentioned Fructus Amomi, Cortex Cinnamomi fine powder mixing, to granulate, the Capsules of packing into is made gastric-dissolved capsule.
Molten part eight flavors of above colon are got Halloysitum Rubrum 4/5 amount, add 10 times of amounts of water, decoct 1 hour, staticly settle, and get supernatant, and are standby; Remaining Halloysitum Rubrum is ground into fine powder, and is standby.Seven flavors such as all the other Rhizoma Corydalis add 13 times of amounts of water, soak after 30 minutes, decoct three times, each 1.5 hours, collecting decoction, filter, filtrate decompression concentrates (below 60 ℃) to about 1.10 (60 ℃) of relative density, room temperature to be chilled to, add ethanol and make that to contain alcohol amount be 60%, stir evenly, left standstill 24 hours, the supernatant of getting supernatant and above-mentioned Halloysitum Rubrum merges, and reclaims ethanol, and concentrating under reduced pressure (below 60 ℃) to relative density is about 1.20 (60 ℃), vacuum drying (below 60 ℃) becomes dry extract, pulverizes; With Halloysitum Rubrum powder mixing, to granulate, the colon soluble and intestine soluble hollow capsule of packing into is made the colon soluble and intestine soluble capsule.
Make 1000 of capsules (wherein gastric solubleness is partly made 667 of gastric-dissolved capsules, and enteric is partly made 333 of colon soluble and intestine soluble capsules).
Embodiment 3: the capsule discrimination method
Used capsular method for making such as embodiment 1 or 2.
Discrimination method comprises to the discriminating of gastric-dissolved capsule with to the molten part of colon to be differentiated:
Wherein the discrimination method of gastric-dissolved capsule comprises following:
The Radix Astragali: get gastric-dissolved capsule content 3g, porphyrize adds n-butyl alcohol 30ml, put in the water-bath reflux 2 hours, and filtered, filtrate is put in the separatory funnel, add 1% sodium hydroxide solution jolting, wash 3 times, each 15ml, discard alkali liquor, the reuse n-butyl alcohol is saturated is washed to neutrality, discards water layer, n-butyl alcohol liquid evaporate to dryness in water-bath, residue adds methanol 1ml makes dissolving, as need testing solution.Get Radix Astragali control medicinal material fine powder 3g,, make the medical material contrast solution according to the preparation method of need testing solution.Other get in gastric solubleness partly the prescription ratio make the negative control sample 3g that lacks the Radix Astragali, prepare negative control solution according to the preparation method of need testing solution.Other gets the astragaloside reference substance, adds methanol and makes the solution that every 1ml contains 1mg, in contrast product solution.Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2005 B), draw need testing solution, medical material contrast solution, negative control solution each 10 μ l, reference substance solution 5 μ l, put respectively on same silica gel g thin-layer plate, lower floor's solution of placing below 10 ℃ with chloroform-methanol-water (13: 7: 2) is developing solvent, launch, take out, dry, spray is with 10% ethanol solution of sulfuric acid, and it is clear to be heated to the speckle colour developing at 105 ℃.In the test sample chromatograph, with reference substance and the corresponding position of control medicinal material chromatograph, daylight shows down identical sepia speckle, ultra-violet lamp (365nm) shows identical orange-yellow fluorescence speckle down.Negative control is noiseless.
The Radix Paeoniae Alba: get gastric-dissolved capsule content 2g, porphyrize adds ethanol 10ml, and jolting 5 minutes filters, and filtrate evaporate to dryness, residue add ethanol 1ml makes dissolving, as need testing solution.Get Radix Paeoniae Alba control medicinal material fine powder 1g,, make the medical material contrast solution according to the preparation method of need testing solution.Get in gastric solubleness partly the prescription ratio make the negative control sample 2g that lacks the Radix Paeoniae Alba, prepare negative control solution according to the preparation method of need testing solution.Other gets the peoniflorin reference substance, adds ethanol and makes every 1ml and contain 1mg solution, in contrast product solution.Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2005 B), draw each 10 μ l of above-mentioned four kinds of solution, put respectively on same silica gel g thin-layer plate, with chloroform-ethyl acetate-methanol-formic acid (40: 5: 10: 0.2) be developing solvent, launch, take out, dry, spray is with 5% vanillin sulfuric acid solution, and it is clear to be heated to the speckle colour developing.In the test sample chromatograph, with reference substance and the corresponding position of control medicinal material chromatograph on, show identical bluish violet speckle
Wherein the molten capsular discrimination method of colon comprises following:
Rhizoma Corydalis: get colon soluble and intestine soluble capsule 's content 4g, porphyrize adds ammonia solution 30ml dissolving, puts in the separatory funnel, and the 50ml jolting that adds diethyl ether is extracted, and divides and gets ether layer, reclaims solvent, and residue adds methanol 1ml makes dissolving, as need testing solution.Get Rhizoma Corydalis control medicinal material fine powder 1g, the saturated ether 30ml of ammonification soaked overnight filters, and filtrate evaporate to dryness, residue add methanol 1ml makes dissolving, in contrast medical material solution.Other get in enteric partly the prescription ratio make the negative control sample 4g that lacks Rhizoma Corydalis, prepare negative control solution according to the preparation method of need testing solution.Get the tetrahydropalmatine reference substance, add methanol and make the solution that every 1ml contains 1mg, in contrast product solution.Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2005 B), draw each 3 μ l of above-mentioned four kinds of solution, put respectively on same silica gel g thin-layer plate, adding 1 strong ammonia solution with normal hexane-chloroform-methanol (7.5: 4: 1) is developing solvent, launch, take out, dry, smoked clear with iodine vapor to the speckle colour developing.Inspect under the daylight, in the test sample chromatograph, with reference substance, the corresponding position of control medicinal material chromatograph on, show the speckle of same color; After in air, waving the iodine that adsorbs on the most plate, put under the ultra-violet lamp (365nm) and inspect, in the test sample chromatograph, with reference substance, the corresponding position of control medicinal material chromatograph on, show the fluorescence speckle of same color.
Fructus Psoraleae: get colon soluble and intestine soluble capsule 's content 1g, add water 20ml dissolving, aqueous solution adds ethyl acetate 30ml extraction, divides and gets ethyl acetate liquid evaporate to dryness, and residue adds ethyl acetate 1ml makes dissolving, as need testing solution.Get Fructus Psoraleae control medicinal material fine powder 0.5g, add ethyl acetate 20ml, ultrasonic 30 minutes, filter, filtrate evaporate to dryness, residue add ethyl acetate 1ml makes dissolving, as the medical material contrast solution.Other get in enteric partly the prescription ratio make the negative control sample 1g that lacks Fructus Psoraleae, prepare negative control solution according to the preparation method of need testing solution.Get psoralen, isopsoralen reference substance, add ethyl acetate and make the mixed solution that every 1ml contains 2mg, in contrast product solution.Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2005 B), draw each 4 μ l of above-mentioned solution, put respectively on same silica gel g thin-layer plate, with normal hexane-ethyl acetate (4: 1) is developing solvent, launch, take out, dry, spray is put under the ultra-violet lamp (365nm) and is inspected with 10% potassium hydroxide methanol solution.In the test sample chromatograph, with reference substance, the corresponding position of control medicinal material chromatograph on, show two identical fluorescence speckles.
Embodiment 4:The capsule content assaying method
Used capsule such as embodiment 1 or 2.
Content assaying method comprises to be measured and to the molten part psoralen of colon assay the content of paeoniflorin of gastric-dissolved capsule:
Content of paeoniflorin is surveyed:
Instrument and reagent:
High performance liquid chromatograph: the P680 of Dai An company pump, PDA-100 diode array detector, ASI-100 automatic sampler
Acetonitrile: chromatographically pure, water: ultra-pure water, other reagent are analytical pure, the peoniflorin reference substance that assay is used is provided by Nat'l Pharmaceutical ﹠ Biological Products Control Institute.
The selection of chromatographic column: adopt the octadecylsilane chemically bonded silica chromatographic column,, can reach the purpose of separation determination through test.Experiment chromatographic column adopting: Dalian Yi Lite ODS-AP 200*4.6mm, 5 μ m;
The selection of mobile phase: acetonitrile-water (17: 83).
The detection wavelength is 230nm, flow velocity 1.0ml/min.
Number of theoretical plate calculates by the peoniflorin peak should be not less than 1500.
The preparation of need testing solution: get gastric-dissolved capsule content 0.3g, the accurate title, decide, and puts in the 25ml measuring bottle, add the about 20ml of methanol, supersound process (power 200W, frequency 59KHz) 30 minutes, put cold, add methanol to scale, shake up, leave standstill, get supernatant, filter with microporous filter membrane (0.45 μ m), get filtrate, promptly.Every of gastric-dissolved capsule contains the Radix Paeoniae Alba with peoniflorin (C 23H 28O 11) meter, must not be less than 3.00mg
The assay of psoralen
Instrument and reagent:
High performance liquid chromatograph: the P680 of Dai An company pump, PDA-100 diode array detector, ASI-100 automatic sampler
Methanol: chromatographically pure, water: ultra-pure water, other reagent are analytical pure, the psoralen reference substance that assay is used is provided by Nat'l Pharmaceutical ﹠ Biological Products Control Institute.
Chromatographic column: octadecylsilane chemically bonded silica chromatographic column; Mobile phase: methanol-water (50: 50); The detection wavelength is 245nm; Flow velocity 0.8ml/min; 25 ℃ of column temperatures.Number of theoretical plate calculates by the psoralen peak should be not less than 2000.
The selection of mobile phase: methanol-1% glacial acetic acid, methanol-acetonitrile-water, methanol-water all can be used as the flow phase system of assay, chromatographic column adopts reversed-phase column (250*4.6mm more, 5 μ m), detect wavelength and be 245nm, column temperature generally is controlled at 25,35,40 ℃.
The preparation of need testing solution: get the content under the colon soluble and intestine soluble capsule content uniformity item, porphyrize is got 0.4g, the accurate title, decide, and puts in the 25ml measuring bottle, adds the about 20ml of methanol, supersound process (power 200W, frequency 59KHz) 30 minutes is put cold, add methanol to scale, shake up, leave standstill, get supernatant, filter with microporous filter membrane (0.45 μ m), get filtrate, promptly.Every of colon soluble and intestine soluble capsule contains Fructus Psoraleae with psoralen (C 11H 6O 3) meter, must not be less than 0.35mg.
Embodiment 5: the capsule method of quality control
Used capsular method for making such as embodiment 1 or 2.
Wherein the discrimination method of gastric-dissolved capsule comprises following method:
The Radix Astragali: get gastric-dissolved capsule content 3g, porphyrize adds n-butyl alcohol 30ml, put in the water-bath reflux 2 hours, and filtered, filtrate is put in the separatory funnel, add 1% sodium hydroxide solution jolting, wash 3 times, each 15ml, discard alkali liquor, the reuse n-butyl alcohol is saturated is washed to neutrality, discards water layer, n-butyl alcohol liquid evaporate to dryness in water-bath, residue adds methanol 1ml makes dissolving, as need testing solution.Get Radix Astragali control medicinal material fine powder 3g,, make the medical material contrast solution according to the preparation method of need testing solution.Other get in gastric solubleness partly the prescription ratio make the negative control sample 3g that lacks the Radix Astragali, prepare negative control solution according to the preparation method of need testing solution.Other gets the astragaloside reference substance, adds methanol and makes the solution that every 1ml contains 1mg, in contrast product solution.Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2005 B), draw need testing solution, medical material contrast solution, negative control solution each 10 μ l, reference substance solution 5 μ l, put respectively on same silica gel g thin-layer plate, lower floor's solution of placing below 10 ℃ with chloroform-methanol-water (13: 7: 2) is developing solvent, launch, take out, dry, spray is with 10% ethanol solution of sulfuric acid, and it is clear to be heated to the speckle colour developing at 105 ℃.In the test sample chromatograph, with reference substance and the corresponding position of control medicinal material chromatograph, daylight shows down identical sepia speckle, ultra-violet lamp (365nm) shows identical orange-yellow fluorescence speckle down [4]Negative control is noiseless.
The Radix Paeoniae Alba: get gastric-dissolved capsule content 2g, porphyrize adds ethanol 10ml, and jolting 5 minutes filters, and filtrate evaporate to dryness, residue add ethanol 1ml makes dissolving, as need testing solution.Get Radix Paeoniae Alba control medicinal material fine powder 1g,, make the medical material contrast solution according to the preparation method of need testing solution.Get in gastric solubleness partly the prescription ratio make the negative control sample 2g that lacks the Radix Paeoniae Alba, prepare negative control solution according to the preparation method of need testing solution.Other gets the peoniflorin reference substance, adds ethanol and makes every 1ml and contain 1mg solution, in contrast product solution.Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2005 B), draw each 10 μ l of above-mentioned four kinds of solution, put respectively on same silica gel g thin-layer plate, with chloroform-ethyl acetate-methanol-formic acid (40: 5: 10: 0.2) be developing solvent, launch, take out, dry, spray is with 5% vanillin sulfuric acid solution, and it is clear to be heated to the speckle colour developing.In the test sample chromatograph, with reference substance and the corresponding position of control medicinal material chromatograph on, show identical bluish violet speckle
Cortex Cinnamomi: get gastric-dissolved capsule content 1.5g, add ethanol 10ml, close plug, merceration 20 minutes, jolting constantly filters, and filtrate is as need testing solution.Get Cortex Cinnamomi control medicinal material fine powder 0.5g,, make control medicinal material solution according to the preparation method of need testing solution.Get in gastric solubleness partly the prescription ratio make and lack cinnamomic negative control sample 1.5g, prepare negative control solution according to the preparation method of need testing solution.Other gets the cinnamic aldehyde reference substance, adds ethanol and makes the reference substance solution that every 1ml contains 1 μ l.Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2005 B), draw each 5 μ l of above-mentioned four kinds of solution, put respectively on same silica gel g thin-layer plate, with petroleum ether (60~90 ℃)-ethyl acetate (17: 3) is developing solvent, launch, take out, dry, spray is with dinitrophenylhydrazine ethanol test solution.In the test sample chromatograph, with reference substance and the corresponding position of control medicinal material chromatograph, show the speckle of same color;
Fructus Amomi: get gastric-dissolved capsule content 2g, porphyrize adds absolute ether 20ml, and merceration spends the night.Filter, filtrate volatilizes naturally, and residue adds dehydrated alcohol 1ml makes dissolving, as need testing solution.Get Fructus Amomi control medicinal material fine powder 0.5g,, make the medical material contrast solution according to the preparation method of need testing solution.Other get in gastric solubleness partly the prescription ratio make the negative control sample 2g that lacks Fructus Amomi, prepare negative control solution according to the preparation method of need testing solution.Get the bornyl acetate reference substance, add dehydrated alcohol and make the solution that every 1ml contains 10 μ l, in contrast product solution.Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2005 B), draw above-mentioned four kinds of each 5ul of solution, respectively with same silica gel g thin-layer plate on, with cyclohexane extraction-ethyl acetate (22: 1) is developing solvent, launch, take out, dry, spray is with 5% vanillin sulfuric acid solution, and it is clear to be heated to the speckle colour developing.In the test sample chromatograph, with reference substance and the corresponding position of control medicinal material chromatograph on, show the speckle of same color.Negative control is noiseless.
Wherein the capsular discrimination method of colon soluble and intestine soluble comprises following:
Rhizoma Corydalis: get colon soluble and intestine soluble capsule 's content 4g, porphyrize adds ammonia solution 30ml dissolving, puts in the separatory funnel, and the 50ml jolting that adds diethyl ether is extracted, and divides and gets ether layer, reclaims solvent, and residue adds methanol 1ml makes dissolving, as need testing solution.Get Rhizoma Corydalis control medicinal material fine powder 1g, the saturated ether 30ml of ammonification soaked overnight filters, and filtrate evaporate to dryness, residue add methanol 1ml makes dissolving, in contrast medical material solution.Other get in enteric partly the prescription ratio make the negative control sample 4g that lacks Rhizoma Corydalis, prepare negative control solution according to the preparation method of need testing solution.Get the tetrahydropalmatine reference substance, add methanol and make the solution that every 1ml contains 1mg, in contrast product solution.Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2005 B), draw each 3 μ l of above-mentioned four kinds of solution, put respectively on same silica gel g thin-layer plate, adding 1 strong ammonia solution with normal hexane-chloroform-methanol (7.5: 4: 1) is developing solvent, launch, take out, dry, smoked clear with iodine vapor to the speckle colour developing.Inspect under the daylight, in the test sample chromatograph, with reference substance, the corresponding position of control medicinal material chromatograph on, show the speckle of same color; After in air, waving the iodine that adsorbs on the most plate, put under the ultra-violet lamp (365nm) and inspect, in the test sample chromatograph, with reference substance, the corresponding position of control medicinal material chromatograph on, show the fluorescence speckle of same color.
Fructus Psoraleae: get colon soluble and intestine soluble capsule 's content 1g, add water 20ml dissolving, aqueous solution adds ethyl acetate 30ml extraction, divides and gets ethyl acetate liquid evaporate to dryness, and residue adds ethyl acetate 1ml makes dissolving, as need testing solution.Get Fructus Psoraleae control medicinal material fine powder 0.5g, add ethyl acetate 20ml, ultrasonic 30 minutes, filter, filtrate evaporate to dryness, residue add ethyl acetate 1ml makes dissolving, as the medical material contrast solution.Other get in enteric partly the prescription ratio make the negative control sample 1g that lacks Fructus Psoraleae, prepare negative control solution according to the preparation method of need testing solution.Get psoralen, isopsoralen reference substance, add ethyl acetate and make the mixed solution that every 1ml contains 2mg, in contrast product solution.Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2005 B), draw each 4 μ l of above-mentioned solution, put respectively on same silica gel g thin-layer plate, with normal hexane-ethyl acetate (4: 1) is developing solvent, launch, take out, dry, spray is put under the ultra-violet lamp (365nm) and is inspected with 10% potassium hydroxide methanol solution.In the test sample chromatograph, with reference substance, the corresponding position of control medicinal material chromatograph on, show two identical fluorescence speckles [12]
Radix Glycyrrhizae: get colon soluble and intestine soluble capsule 's content 5g, porphyrize adds chloroform 40ml, supersound process 20 minutes filters, and discards filtrate, filtering residue adds methanol 50ml, and supersound process 20 minutes filters, filtrate is concentrated into about 5ml, is added on the neutral alumina post (100~200 orders, the 15g that have handled well, on the internal diameter 10~15mm),, collect eluent with 40% methanol 150ml eluting, evaporate to dryness, residue adds water 30ml makes dissolving, with water saturated n-butanol extraction 2 times, and each 25ml, merge n-butyl alcohol liquid, with ammonia scrubbing 3 times, each 20ml, n-butyl alcohol liquid is put evaporate to dryness in the water-bath, residue adds the 1ml dissolve with methanol, as need testing solution.Extracting liquorice control medicinal material fine powder 2g according to the preparation method of need testing solution, makes control medicinal material solution.Other get in enteric partly the prescription ratio make the negative control sample 5g that lacks Radix Glycyrrhizae, prepare negative control solution according to the preparation method of need testing solution.Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2005 B), draw above-mentioned three kinds of each 8ul of solution, put respectively on same silica gel g thin-layer plate, (15: 40: 22: 10) lower floor's solution of placing below 10 ℃ was developing solvent with chloroform-ethyl acetate-methanol-water, launch, take out, dry, spray is with 10% ethanol solution of sulfuric acid, and it is clear to be heated to the speckle colour developing at 105 ℃.Inspect under the daylight, in the test sample chromatograph, with the corresponding position of control medicinal material chromatograph on, show the speckle of same color; Put under the ultra-violet lamp (365nm) and inspect, in the test sample chromatograph, with the corresponding position of control medicinal material chromatograph on, show the fluorescence speckle of same color.
Radix Saposhnikoviae: get colon soluble and intestine soluble capsule 's content 1g, porphyrize adds acetone 20ml, and supersound process 20 minutes filters, and filtrate evaporate to dryness, residue add ethanol 1ml makes dissolving, as need testing solution.Get Radix Saposhnikoviae control medicinal material fine powder 1g,, make control medicinal material solution according to the preparation method of need testing solution.Other get in enteric partly the prescription ratio make the negative control sample 1g that lacks Radix Saposhnikoviae, prepare negative control solution according to the preparation method of need testing solution.According to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2005 B) test, draw each 15 μ l of above-mentioned three kinds of solution, put in same silica gel G F respectively 254On the lamellae, be developing solvent, launch, take out, dry, put under the uviol lamp (254nm) and inspect with chloroform-methanol (8: 1).In the test sample chromatograph, with the corresponding position of control medicinal material on, show the speckle of same color.
Content assaying method comprises to be measured and to the molten part psoralen of colon assay the content of paeoniflorin of gastric-dissolved capsule:
Content of paeoniflorin is surveyed:
Instrument and reagent:
High performance liquid chromatograph: the P680 of Dai An company pump, PDA-100 diode array detector, ASI-100 automatic sampler
Acetonitrile: chromatographically pure, water: ultra-pure water, other reagent are analytical pure, the peoniflorin reference substance that assay is used is provided by Nat'l Pharmaceutical ﹠ Biological Products Control Institute.
The selection of chromatographic column: adopt the octadecylsilane chemically bonded silica chromatographic column,, can reach the purpose of separation determination through test.Experiment chromatographic column adopting: Dalian Yi Lite ODS-AP 200*4.6mm, 5 μ m;
The selection of mobile phase: acetonitrile-water (17: 83).
The detection wavelength is 230nm, flow velocity 1.0ml/min.
Number of theoretical plate calculates by the peoniflorin peak should be not less than 1500.
The preparation of need testing solution: get gastric-dissolved capsule content 0.3g, the accurate title, decide, and puts in the 25ml measuring bottle, add the about 20ml of methanol, supersound process (power 200W, frequency 59KHz) 30 minutes, put cold, add methanol to scale, shake up, leave standstill, get supernatant, filter with microporous filter membrane (0.45 μ m), get filtrate, promptly.Every of gastric-dissolved capsule contains the Radix Paeoniae Alba with peoniflorin (C 23H 28O 11) meter, must not be less than 3.00mg
The assay of psoralen
Instrument and reagent:
High performance liquid chromatograph: the P680 of Dai An company pump, PDA-100 diode array detector, ASI-100 automatic sampler
Methanol: chromatographically pure, water: ultra-pure water, other reagent are analytical pure, the psoralen reference substance that assay is used is provided by Nat'l Pharmaceutical ﹠ Biological Products Control Institute.
Chromatographic column: octadecylsilane bonded chromatographic post; Mobile phase: methanol-water (50: 50); The detection wavelength is 245nm; Flow velocity 0.8ml/min; 25 ℃ of column temperatures.Number of theoretical plate calculates by the psoralen peak should be not less than 2000.
The preparation of need testing solution: get the colon soluble and intestine soluble capsule 's content, porphyrize is got 0.4g, the accurate title, decide, and puts in the 25ml measuring bottle, adds the about 20ml of methanol, supersound process (power 200W, frequency 59KHz) 30 minutes is put cold, add methanol to scale, shake up, leave standstill, get supernatant, filter with microporous filter membrane (0.45 μ m), get filtrate, promptly.Fructus Psoraleae is with psoralen (C 11H 6O 3) meter, must not be less than 0.35mg.

Claims (7)

1, a kind of Chinese medicinal capsule preparation with functions of reinforcing spleen and benefiting intestine is characterized in that the said preparation crude drug partly is made up of gastric solubleness part, the molten part two of colon, wherein the gastric solubleness part:
Radix Astragali 150-250 weight portion Radix Codonopsis 100-200 weight portion Fructus Amomi 40-80 weight portion
Radix Paeoniae Alba 250-400 weight portion Radix Angelicae Sinensis 30-70 weight portion Rhizoma Atractylodis Macrocephalae 70-140 weight portion
Cortex Cinnamomi 20-40 weight portion, wherein Radix Codonopsis is that rice is fried, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae are parching with earth;
The molten part of colon wherein:
Rhizoma Corydalis (processed) 70-140 weight portion Semen Litchi 70-140 weight portion
Gun ginger 40-90 weight portion Radix Glycyrrhizae Preparata 70-140 weight portion
Radix Saposhnikoviae 70-140 weight portion Radix Aucklandiae 70-140 weight portion
Processed with salt Fructus Psoraleae 70-140 weight portion Halloysitum Rubrum(calcined) 250-350 weight portion;
Wherein gastric solubleness part, the molten part of colon prepare respectively, and the capsule quantity that gastric solubleness is partly made is 2 times that the molten part of colon is made capsule quantity.
2, Chinese medicinal capsule preparation as claimed in claim 1 is characterized in that the said preparation crude drug is made up of following raw material medicaments:
The gastric solubleness part:
The Radix Astragali 220 weight portion Radix Codonopsis 160 weight portion Fructus Amomis 50 weight portions
The Radix Paeoniae Alba 320 weight portion Radix Angelicae Sinensis 40 weight portion Rhizoma Atractylodis Macrocephalaes 90 weight portions
Cortex Cinnamomi 30 weight portions;
The molten part of colon:
Rhizoma Corydalis 110 weight portion Semen Litchis 120 weight portion Rhizoma Zingiberiss 70 weight portions
The Radix Glycyrrhizae 110 weight portion Radix Saposhnikoviaes 100 weight portion Radix Aucklandiae 80 weight portions
Fructus Psoraleae 90 weight portion Halloysitum Rubrums 280 weight portions.
3, Chinese medicinal capsule preparation as claimed in claim 1 or 2 is characterized in that the said preparation preparation method is: gastric solubleness part seven flavor, get Fructus Amomi, Cortex Cinnamomi powder is broken into fine powder, sieves mixing; The five tastes such as all the other Radixs Astragali add water 8-12 doubly to be measured, and soaks after 20-40 minute, decocts 2-3 time, each 1-3 hour, collecting decoction filtered, filtrate decompression is concentrated into relative density 1.10, and room temperature to be chilled to adds ethanol and makes the alcohol amount of containing be 50-70%, stir evenly, after leaving standstill, get supernatant and reclaim ethanol, being evaporated to relative density is 1.20, vacuum drying becomes dry extract, pulverizes; With above-mentioned Fructus Amomi, Cortex Cinnamomi fine powder mixing, to granulate, the Capsules of packing into is made gastric-dissolved capsule;
Molten part eight flavors of colon are got Halloysitum Rubrum 4/5 amount, add water 8-12 and doubly measure, and decoct 1-2 hour, staticly settle, and get supernatant, and are standby; Remaining Halloysitum Rubrum is ground into fine powder, and is standby; Seven flavors such as all the other Rhizoma Corydalis add water 11-15 doubly to measure, and soak after 20-40 minute, decoct 2-4 time, each 1-2 hour, collecting decoction, filter, filtrate decompression is concentrated into relative density 1.10, room temperature to be chilled to, add ethanol and make the alcohol amount of containing be 50-70%, stir evenly, leave standstill, the supernatant of getting supernatant and above-mentioned Halloysitum Rubrum merges, and reclaims ethanol, is evaporated to relative density 1.20, vacuum drying becomes dry extract, pulverizes; With Halloysitum Rubrum powder mixing, to granulate, the colon soluble and intestine soluble hollow capsule of packing into is made the colon soluble and intestine soluble capsule.
4, Chinese medicinal capsule preparation as claimed in claim 3 is characterized in that the said preparation preparation method is: gastric solubleness part seven flavor, get Fructus Amomi, Cortex Cinnamomi powder is broken into fine powder, sieves mixing; The five tastes such as all the other Radixs Astragali add 10 times of amounts of water, soak after 30 minutes, decoct secondary, each 2 hours, collecting decoction filtered, filtrate is evaporated to 60 ℃ of relative densities below 60 ℃ about 1.10, and room temperature to be chilled to adds ethanol and makes that to contain the alcohol amount be 60%, stir evenly, after leaving standstill 24 hours, get supernatant and reclaim ethanol, being evaporated to relative density below 60 ℃ is 1.20 for about 60 ℃, vacuum drying becomes dry extract below 60 ℃, pulverizes; With above-mentioned Fructus Amomi, Cortex Cinnamomi fine powder mixing, to granulate, the Capsules of packing into is made gastric-dissolved capsule;
Molten part eight flavors of colon are got Halloysitum Rubrum 4/5 amount, add 10 times of amounts of water, decoct 1 hour, staticly settle, and get supernatant, and are standby; Remaining Halloysitum Rubrum is ground into fine powder, and is standby; Seven flavors such as all the other Rhizoma Corydalis add 13 times of amounts of water, soak after 30 minutes, decoct three times, each 1.5 hours, collecting decoction, filtrate is evaporated to 60 ℃ of relative densities below 60 ℃ about 1.10, and room temperature to be chilled to adds ethanol and makes that to contain the alcohol amount be 60%, stir evenly, left standstill 24 hours, the supernatant of getting supernatant and above-mentioned Halloysitum Rubrum merges, reclaim ethanol, being evaporated to 60 ℃ of relative densities below 60 ℃ is that vacuum drying becomes dry extract below 1.20,60 ℃, pulverizes; With Halloysitum Rubrum powder mixing, to granulate, the colon soluble and intestine soluble hollow capsule of packing into is made the colon soluble and intestine soluble capsule.
5, Chinese medicinal capsule preparation as claimed in claim 1 or 2 is characterized in that the discriminating of said preparation comprises following method, and wherein the discriminating of gastric-dissolved capsule comprises one or more in the following method:
A. the Radix Astragali: get gastric-dissolved capsule content 3g, porphyrize adds n-butyl alcohol 30ml, put in the water-bath reflux 2 hours, and filtered, filtrate is put in the separatory funnel, add 1% sodium hydroxide solution jolting, wash 3 times, each 15ml, discard alkali liquor, the reuse n-butyl alcohol is saturated is washed to neutrality, discards water layer, n-butyl alcohol liquid evaporate to dryness in water-bath, residue adds methanol 1ml makes dissolving, as need testing solution; Get Radix Astragali control medicinal material fine powder 3g,, make the medical material contrast solution according to the preparation method of need testing solution; Other gets the astragaloside reference substance, adds methanol and makes the solution that every 1ml contains 1mg, in contrast product solution; According to thin layer chromatography (" an appendix VI of Chinese pharmacopoeia version in 2005 B) test, draw need testing solution, medical material contrast solution, reference substance solution 5 μ l, put respectively on same silica gel g thin-layer plate, with 12-15: 6-8: lower floor's solution that 1-3 chloroform-methanol-water is placed below 10 ℃ is developing solvent, launch, take out, dry, spray is with 10% ethanol solution of sulfuric acid, and it is clear to be heated to the speckle colour developing at 105 ℃; In the test sample chromatograph, with reference substance and the corresponding position of control medicinal material chromatograph, daylight shows down identical sepia speckle, the 365nm ultra-violet lamp shows identical orange-yellow fluorescence speckle down;
B. the Radix Paeoniae Alba: get gastric-dissolved capsule content 2g, porphyrize adds ethanol 10ml, and jolting 5 minutes filters, and filtrate evaporate to dryness, residue add ethanol 1ml makes dissolving, as need testing solution; Get Radix Paeoniae Alba control medicinal material fine powder 1g,, make the medical material contrast solution according to the preparation method of need testing solution; Other gets the peoniflorin reference substance, adds ethanol and makes every 1ml and contain 1mg solution, in contrast product solution; According to thin layer chromatography (" an appendix VI of Chinese pharmacopoeia version in 2005 B) test, draw each 10 μ l of above-mentioned three kinds of solution, put respectively on same silica gel g thin-layer plate, with 35-45: 3-7: 8-12: 0.1-0.4 chloroform-ethyl acetate-methanol-formic acid is developing solvent, launch, take out, dry, spray is with 5% vanillin sulfuric acid solution, and it is clear to be heated to the speckle colour developing; In the test sample chromatograph, with reference substance and the corresponding position of control medicinal material chromatograph on, show identical bluish violet speckle;
C. Cortex Cinnamomi: get gastric-dissolved capsule content 1.5g, add ethanol 10ml, close plug, merceration 20 minutes, jolting constantly filters, and filtrate is as need testing solution; Get Cortex Cinnamomi control medicinal material fine powder 0.5g,, make control medicinal material solution according to the preparation method of need testing solution; Other gets the cinnamic aldehyde reference substance, adds ethanol and makes the reference substance solution that every 1ml contains 1 μ l; According to thin layer chromatography test, draw each 5 μ l of above-mentioned three kinds of solution, put respectively on same silica gel g thin-layer plate, with 15-19: 60~90 ℃-ethyl acetate of 2-4 petroleum ether is developing solvent, launches, and takes out, and dries, and spray is with dinitrophenylhydrazine ethanol test solution; In the test sample chromatograph, with reference substance and the corresponding position of control medicinal material chromatograph, show the speckle of same color;
D. Fructus Amomi: get gastric-dissolved capsule content 2g, porphyrize adds absolute ether 20ml, and merceration spends the night; Filter, filtrate volatilizes naturally, and residue adds dehydrated alcohol 1ml makes dissolving, as need testing solution; Get Fructus Amomi control medicinal material fine powder 0.5g,, make the medical material contrast solution according to the preparation method of need testing solution; Get the bornyl acetate reference substance, add dehydrated alcohol and make the solution that every 1ml contains 10 μ l, in contrast product solution; According to thin layer chromatography test, draw above-mentioned three kinds of each 5ul of solution, respectively with same silica gel g thin-layer plate on, with 20-24: 1 cyclohexane extraction-ethyl acetate is developing solvent, launches, and takes out, and dries, spray is with 5% vanillin sulfuric acid solution, be heated to speckle develop the color clear; In the test sample chromatograph, with reference substance and the corresponding position of control medicinal material chromatograph on, show the speckle of same color;
Wherein the molten capsular discriminating of colon comprises one or more in the following method:
E. Rhizoma Corydalis: get colon soluble and intestine soluble capsule 's content 4g, porphyrize adds ammonia solution 30ml dissolving, puts in the separatory funnel, and the 50ml jolting that adds diethyl ether is extracted, and divides and gets ether layer, reclaims solvent, and residue adds methanol 1ml makes dissolving, as need testing solution; Get Rhizoma Corydalis control medicinal material fine powder 1g, the saturated ether 30ml of ammonification soaked overnight filters, and filtrate evaporate to dryness, residue add methanol 1ml makes dissolving, in contrast medical material solution; Get the tetrahydropalmatine reference substance, add methanol and make the solution that every 1ml contains 1mg, in contrast product solution; According to thin layer chromatography test, draw each 3 μ l of above-mentioned three kinds of solution, put respectively on same silica gel g thin-layer plate, with 6-8: 3-5: it is developing solvent that 1 normal hexane-chloroform-methanol adds 1 strong ammonia solution, launches, and takes out, and dries, smoked clear to the speckle colour developing with iodine vapor; Inspect under the daylight, in the test sample chromatograph, with reference substance, the corresponding position of control medicinal material chromatograph on, show the speckle of same color; After in air, waving the iodine that adsorbs on the most plate, put under the 365nm ultra-violet lamp and inspect, in the test sample chromatograph, with reference substance, the corresponding position of control medicinal material chromatograph on, show the fluorescence speckle of same color;
F. Fructus Psoraleae: get colon soluble and intestine soluble capsule 's content 1g, add water 20ml dissolving, aqueous solution adds ethyl acetate 30ml extraction, divides and gets ethyl acetate liquid evaporate to dryness, and residue adds ethyl acetate 1ml makes dissolving, as need testing solution; Get Fructus Psoraleae control medicinal material fine powder 0.5g, add ethyl acetate 20ml, ultrasonic 30 minutes, filter, filtrate evaporate to dryness, residue add ethyl acetate 1ml makes dissolving, as the medical material contrast solution; Get psoralen, isopsoralen reference substance, add ethyl acetate and make the mixed solution that every 1ml contains 2mg, in contrast product solution; According to thin layer chromatography test, draw each 4 μ l of above-mentioned solution, put respectively on same silica gel g thin-layer plate, with 3-5: 1-2 normal hexane-ethyl acetate is developing solvent, launches, and takes out, and dries, and spray is put under the ultra-violet lamp 365nm and inspected with 10% potassium hydroxide methanol solution; In the test sample chromatograph, with reference substance, the corresponding position of control medicinal material chromatograph on, show two identical fluorescence speckles;
G. Radix Glycyrrhizae: get colon soluble and intestine soluble capsule 's content 5g, porphyrize adds chloroform 40ml, supersound process 15-30 minute, filter, discard filtrate, filtering residue adds methanol 50ml, supersound process 15-30 minute, filters, filtrate is concentrated into about 5ml, is added on neutral alumina post 100~200 orders of having handled well, 15g, on internal diameter 10~15mm,, collect eluent with 40% methanol 150ml eluting, evaporate to dryness, residue adds water 30ml makes dissolving, with water saturated n-butanol extraction 2-3 time, and each 25ml, merge n-butyl alcohol liquid, with ammonia scrubbing 2-4 time, each 20ml, n-butyl alcohol liquid is put evaporate to dryness in the water-bath, residue adds the 1ml dissolve with methanol, as need testing solution; Extracting liquorice control medicinal material fine powder 2g according to the preparation method of need testing solution, makes control medicinal material solution; Test according to thin layer chromatography, draw above-mentioned two kinds of each 8ul of solution, put respectively on same silica gel g thin-layer plate, with 13-17: 38-45: 20-25: lower floor's solution that 8-12 chloroform-ethyl acetate-methanol-water is placed below 10 ℃ is developing solvent, launch, take out, dry, spray is with 10% ethanol solution of sulfuric acid, and it is clear to be heated to the speckle colour developing at 105 ℃; Inspect under the daylight, in the test sample chromatograph, with the corresponding position of control medicinal material chromatograph on, show the speckle of same color; Put under the ultra-violet lamp 365nm and inspect, in the test sample chromatograph, with the corresponding position of control medicinal material chromatograph on, show the fluorescence speckle of same color;
H. the thin layer chromatography identification experiment of Radix Saposhnikoviae: get colon soluble and intestine soluble capsule 's content 1g, porphyrize adds acetone 20ml, and supersound process 15-25 minute, filter, filtrate evaporate to dryness, residue add ethanol 1ml makes dissolving, as need testing solution; Get Radix Saposhnikoviae control medicinal material fine powder 1g,, make control medicinal material solution according to the preparation method of need testing solution; According to the thin layer chromatography test, draw each 15 μ l of above-mentioned two kinds of solution, put in same silica gel G F respectively 254On the lamellae, with 7-9: 1 chloroform-methanol is developing solvent, launches, and takes out, and dries, and puts under the uviol lamp 254nm and inspects; In the test sample chromatograph, with the corresponding position of control medicinal material on, show the speckle of same color.
6, Chinese medicinal capsule preparation as claimed in claim 1 or 2 is characterized in that the determination in the method for quality control of said preparation comprises following method:
A. content of paeoniflorin is measured:
The selection of chromatographic column: adopt the octadecylsilane chemically bonded silica chromatographic column;
The selection of mobile phase: the ratio of acetonitrile-water is 15-19: 75-88
The detection wavelength is 230nm, flow velocity 1.0ml/min;
Number of theoretical plate calculates by the peoniflorin peak should be not less than 1500;
The preparation of need testing solution: get gastric-dissolved capsule content 0.3g, the accurate title, decide, and puts in the 25ml measuring bottle, add the about 20ml of methanol, supersound process, power, 150-300W, frequency, 40-70KHz, 20-40 minute, put coldly, add methanol to scale, shake up, leave standstill, get supernatant, filter with 0.45 μ m microporous filter membrane, get filtrate, promptly;
B. the assay of psoralen:
Chromatographic column: octadecylsilane chemically bonded silica chromatographic column; The methanol of mobile phase: 45-55: 45-55-1% glacial acetic acid or methanol-acetonitrile-water or methanol-water; The detection wavelength is 245nm; Flow velocity 0.8ml/min; Column temperature 25-40 ℃; Number of theoretical plate calculates by the psoralen peak should be not less than 2000;
The preparation of need testing solution: get colon soluble and intestine soluble capsule 's content 0.4g, put in the 25ml measuring bottle, add the about 20ml of methanol, supersound process power, 150-300W, frequency, 40-70KHz 20-40 minute, is put cold, add methanol to scale, shake up, leave standstill, get supernatant, filter with 0.45 μ m microporous filter membrane, get filtrate, promptly.
7, Chinese medicinal capsule preparation as claimed in claim 6 is characterized in that the determination in the method for quality control of said preparation comprises following method:
Content of paeoniflorin is surveyed:
The selection of chromatographic column: octadecylsilane chemically bonded silica chromatographic column
The selection of mobile phase: 17: 83 acetonitrile-water;
The detection wavelength is 230nm, flow velocity 1.0ml/min;
Number of theoretical plate calculates by the peoniflorin peak should be not less than 1500;
The preparation of need testing solution: get gastric-dissolved capsule content 0.3g, the accurate title, decide, and puts in the 25ml measuring bottle, add the about 20ml of methanol, supersound process, power 200W, frequency 59KHz 30 minutes, is put cold, add methanol to scale, shake up, leave standstill, get supernatant, filter with 0.45 μ m microporous filter membrane, get filtrate, promptly;
The assay of psoralen:
Chromatographic column: octadecylsilane chemically bonded silica chromatographic column; Mobile phase: 50: 50 methanol-water; The detection wavelength is 245nm; Flow velocity 0.8ml/min; 25 ℃ of column temperatures; Number of theoretical plate calculates by the psoralen peak should be not less than 2000;
The preparation of need testing solution: get the content under the colon soluble and intestine soluble capsule content uniformity item, porphyrize is got 0.4g, the accurate title, decide, and puts in the 25ml measuring bottle, adds the about 20ml of methanol, supersound process, power 200W, frequency 59KHz, 30 minutes, put coldly, add methanol to scale, shake up, leave standstill, get supernatant, filter with 0.45 μ m microporous filter membrane, get filtrate, promptly.
CN 200510114587 2005-10-26 2005-10-26 Chinese medicinal capsule for treating ulcerative colitis Active CN1768854B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510114587 CN1768854B (en) 2005-10-26 2005-10-26 Chinese medicinal capsule for treating ulcerative colitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510114587 CN1768854B (en) 2005-10-26 2005-10-26 Chinese medicinal capsule for treating ulcerative colitis

Publications (2)

Publication Number Publication Date
CN1768854A true CN1768854A (en) 2006-05-10
CN1768854B CN1768854B (en) 2010-05-12

Family

ID=36750559

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510114587 Active CN1768854B (en) 2005-10-26 2005-10-26 Chinese medicinal capsule for treating ulcerative colitis

Country Status (1)

Country Link
CN (1) CN1768854B (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102641482A (en) * 2011-10-10 2012-08-22 山东仙河药业有限公司 Preparation method of capsule for treating gastrointestinal diseases
CN102698145A (en) * 2012-06-19 2012-10-03 大连民族学院 Chinese medicine preparation for tonifying spleen and stopping diarrhea
CN103185767A (en) * 2012-12-11 2013-07-03 河南省康星药业股份有限公司 Method for identifying psoralen and isopsoralen in aphrodisiac submicron powder for improving laying rate and egg weight
CN103439449A (en) * 2013-07-25 2013-12-11 广东远大药业有限公司 Detection method of medicine used for nourishing lung and activating blood
CN106053707A (en) * 2016-06-24 2016-10-26 广西灵峰药业有限公司 Production quality control method of medicated tortoise jelly
CN106645545A (en) * 2017-03-09 2017-05-10 曹礼静 Thin-layer chromatographic identification method for licorice root and application thereof
CN110118834A (en) * 2019-05-23 2019-08-13 贵州远程制药有限责任公司 A kind of quality determining method for phlegm asthma pharmaceutical composition
CN110389179A (en) * 2018-04-19 2019-10-29 中日友好医院 A kind of detection method of Chinese medicine composition
CN110398562A (en) * 2019-07-23 2019-11-01 株洲千金药业股份有限公司 The TLC Identification of Radix Glycyrrhizae in a kind of Fuke Tiaojing tablets
CN110702834A (en) * 2019-09-27 2020-01-17 石家庄平安医院有限公司 Non-interference rapid thin-layer identification method for kidney-tonifying toxin-expelling granules

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1003978B (en) * 1987-09-05 1989-04-26 广州陈李济药厂 Preparing process of stomach-solvable type and intestinn-solvable type integsated pill-ready-made traditional chinese medicine

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102641482A (en) * 2011-10-10 2012-08-22 山东仙河药业有限公司 Preparation method of capsule for treating gastrointestinal diseases
CN102698145A (en) * 2012-06-19 2012-10-03 大连民族学院 Chinese medicine preparation for tonifying spleen and stopping diarrhea
CN103185767A (en) * 2012-12-11 2013-07-03 河南省康星药业股份有限公司 Method for identifying psoralen and isopsoralen in aphrodisiac submicron powder for improving laying rate and egg weight
CN103439449A (en) * 2013-07-25 2013-12-11 广东远大药业有限公司 Detection method of medicine used for nourishing lung and activating blood
CN103439449B (en) * 2013-07-25 2015-07-29 广东远大药业有限公司 A kind of detection method of medicine of invigorating blood circulation for tonifying lung
CN106053707A (en) * 2016-06-24 2016-10-26 广西灵峰药业有限公司 Production quality control method of medicated tortoise jelly
CN106645545A (en) * 2017-03-09 2017-05-10 曹礼静 Thin-layer chromatographic identification method for licorice root and application thereof
CN110389179A (en) * 2018-04-19 2019-10-29 中日友好医院 A kind of detection method of Chinese medicine composition
CN110118834A (en) * 2019-05-23 2019-08-13 贵州远程制药有限责任公司 A kind of quality determining method for phlegm asthma pharmaceutical composition
CN110118834B (en) * 2019-05-23 2021-07-30 贵州远程制药有限责任公司 Quality detection method for phlegmatic asthma medicine composition
CN110398562A (en) * 2019-07-23 2019-11-01 株洲千金药业股份有限公司 The TLC Identification of Radix Glycyrrhizae in a kind of Fuke Tiaojing tablets
CN110702834A (en) * 2019-09-27 2020-01-17 石家庄平安医院有限公司 Non-interference rapid thin-layer identification method for kidney-tonifying toxin-expelling granules
CN110702834B (en) * 2019-09-27 2021-08-10 石家庄平安医院有限公司 Non-interference rapid thin-layer identification method for kidney-tonifying toxin-expelling granules

Also Published As

Publication number Publication date
CN1768854B (en) 2010-05-12

Similar Documents

Publication Publication Date Title
CN1768854A (en) Chinese medicinal capsule with spleen-supplementing, intestine-benefiting function
CN1895617A (en) Kidney-warming and heart-nourishing Chinese-medicinal preparation, its making method and quality control
CN101040915A (en) Method for preparing a Shuanhuanglian injection and the component detecting method
CN1457829A (en) Chinese medicine composition for curing chronic atrophic sastritis and its preparing method and quality control method
CN1843425A (en) Dispersion tablet for getting brain and heart unobstructed and preparation method and its quality control method
CN1876161A (en) Pharmaceutical formulation and preparing method for breast nodules for treating hyperplasia of mammary glands, and its quality control method
CN1876089A (en) A pharmaceutical composition for treating kidney-qi deficiency syndrome and preparation method thereof
CN1698878A (en) Kidney replenishing medicinal composition and its preparation process and novel use
CN1943680A (en) A Chinese traditional medicinal composition for treatment of endometriosis and its preparation method
CN1305512C (en) Traditional Chinese medicine compound recipe for treating hyperplasia of mammary glands and preparation method thereof
CN1872199A (en) Composition of Chinese traditional medicine, and preparation method
CN1899536A (en) Medicine for treating diabetes and hephrosis and its preparing method
CN1954867A (en) Medical preparation of nodules of breast for treating gynaopathy and preparation method and quality control method
CN100336544C (en) Chinese medicinal composition with beautifying function and method for preparing the same
CN1806845A (en) Medicinal composition, its preparation process and quality control method
CN1586612A (en) Process for preparing granular powder for treating blood stasis disease and quality control method
CN1299734C (en) Composition of traditional Chinese medicine for large intestine hygropyretic disease and its preparation method
CN1291734C (en) Method for preparing and controlling the quality of Chinese medicinal soft capsule
CN1768780A (en) Pharmaceutical composition for treating ulcerative colitis, its preparation method and use
CN1194743C (en) Chinese medicinal composition for treating atrophic arthritis, preparing method and quality controlling method thereof
CN1850268A (en) Semen caesalpiniae Chinese medicine preparation for treating cold, its preparing method and quality control method
CN1879849A (en) Compound capsule with pseudo-ginseng and Chinese fanpalm seed, its preparation process and quality control method
CN1872321A (en) Composition of Chinese traditional medicine for treating alcoholic hepatitis, and preparation method
CN1303980C (en) Orally quick releasing tablet of compound red sage root, its medical uses and preparation process
CN1714805A (en) Medicine development and preparation using absorbed and metabolized natural medicine component as main component

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
DD01 Delivery of document by public notice

Addressee: Ma Penggang

Document name: Notification that Application Deemed not to be Proposed

C56 Change in the name or address of the patentee

Owner name: CHINA RESOURCES SANJIU MEDICAL + PHARMACEUTICAL CO

Free format text: FORMER NAME: SANJIU PHARMACEUTICAL CO., LTD.

CP01 Change in the name or title of a patent holder

Address after: 518029 Guangdong Province, Shenzhen City Lake Road South pharmaceutical equipment in building four - six storey

Patentee after: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Address before: 518029 Guangdong Province, Shenzhen City Lake Road South pharmaceutical equipment in building four - six storey

Patentee before: Sanjiu Pharmaceutical Co., Ltd.